Co-Diagnostics, Inc. (CODX) Insider Trading Activity

OTC$2.83+0.02 (0.71%)
Market Cap
$3.14M
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
—
Rank in Industry
—

CODX Insider Trading Activity

CODX Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$
–
Sells
$
–

Related Transactions

About Co-Diagnostics, Inc.

Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is based in Salt Lake City, Utah.

Insider Activity of Co-Diagnostics, Inc.

Over the last 12 months, insiders at Co-Diagnostics, Inc. have bought $undefined and sold $undefined worth of Co-Diagnostics, Inc. stock.

On average, over the past 5 years, insiders at Co-Diagnostics, Inc. have bought $5,697 and sold $944,538 worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 3,000 shares for transaction amount of $5,697 was made by Brown Brian Lee (Chief Financial Officer) on 2023‑03‑20.

List of Insider Buy and Sell Transactions, Co-Diagnostics, Inc.

2023-03-20Purchase
Brown Brian Lee
Chief Financial Officer
3,000
0.0095%
$1.90
$5,697
-35.79%
2021-09-08Sale
Durenard Eugene
director
2,000
0.007%
$10.46
$20,910
-37.92%
2021-05-19Sale
BENSON REED L
General Counsel
108,334
0.3747%
$8.53
$923,628
-1.52%
2021-01-15Sale
Egan Dwight H
Chief Executive Officer
38,046
0.1385%
$11.00
$418,506
-13.05%
2021-01-14Sale
SERBIN RICHARD S
director
10,000
0.0353%
$10.29
$102,900
-9.74%
2021-01-13Sale
Durenard Eugene
director
21,000
0.0734%
$10.09
$211,890
-8.44%
2021-01-13Sale
NELSON JAMES B
director
25,000
0.0877%
$10.13
$253,262
-8.44%
2020-12-14Sale
SERBIN RICHARD S
director
34,000
0.1206%
$10.10
$343,400
-11.77%
2020-12-10Sale
Durenard Eugene
director
20,000
0.0726%
$10.15
$203,000
-9.03%
2020-11-25Sale
BENSON REED L
CFO and Secretary
179,048
0.5796%
$10.50
$1.88M
-20.35%
2020-11-24Sale
Egan Dwight H
Chief Executive Officer
89,528
0.3335%
$10.51
$940,939
-8.38%
2020-11-23Sale
Egan Dwight H
Chief Executive Officer
143,138
0.5331%
$10.44
$1.49M
-7.67%
2020-11-20Sale
Egan Dwight H
Chief Executive Officer
36,034
0.1349%
$11.09
$399,617
-12.53%
2020-05-28Sale
SERBIN RICHARD S
director
42,500
0.159%
$18.02
$766,050
-23.13%
2020-05-26Sale
Durenard Eugene
director
25,000
0.0917%
$18.24
$456,000
-25.35%
2020-05-20Sale
Durenard Eugene
director
50,000
0.1769%
$18.14
$906,750
-26.83%
2020-05-19Sale
SERBIN RICHARD S
director
50,000
0.1779%
$18.50
$925,000
-27.85%
2018-05-11Purchase
Satterfield Brent
Chief Science Officer
2,610
0.0209%
$1.82
$4,750
+21.47%
2018-05-03Purchase
Satterfield Brent
Chief Science Officer
1,000
0.0081%
$1.91
$1,910
+16.75%
2018-04-23Purchase
Satterfield Brent
Chief Science Officer
1,000
0.0083%
$2.02
$2,020
+12.63%
Total: 22

CODX Institutional Investors: Active Positions

Increased Positions12+30.77%25,725+14.98%
Decreased Positions13-33.33%10,162-5.92%
New Positions3New787New
Sold Out Positions5Sold Out2,432Sold Out
Total Postitions38-2.56%187,281+9.06%

CODX Ownership Change vs Market

No data is available at this moment.

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Vanguard Group Inc$316.002.84%56,859-910-1.57%2025-09-30
Private Advisory Group Llc$219.001.97%39,38400%2025-09-30
Renaissance Technologies Llc$161.001.45%28,915+10,216+54.63%2025-09-30
Blackrock, Inc.$79.000.71%14,24700%2025-09-30
Geode Capital Management, Llc$59.000.53%10,66500%2025-09-30
Hrt Financial Lp$28.000.25%4,976+4,533+1,023.25%2025-09-30
Bank Of New York Mellon Corp$25.000.23%4,56800%2025-09-30
Kestra Advisory Services, Llc$25.000.22%4,489+201+4.69%2025-09-30
Virtu Financial Llc$23.000.21%4,217+3,363+393.79%2025-09-30
Ubs Group Ag$22.000.2%3,941+3,899+9,283.33%2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.